For nearly a century developmental biologists have recognized that cells from embryos can differ in their potential to differentiate into distinct cell types. Recently, it has been recognized that embryonic stem cells derived from both mice and humans exhibit two stable yet epigenetically distinct states of pluripotency: naive and primed. We now show that nicotinamide N-methyltransferase (NNMT) and the metabolic state regulate pluripotency in human embryonic stem cells (hESCs). Specifically, in naive hESCs, NNMT and its enzymatic product 1-methylnicotinamide are highly upregulated, and NNMT is required for low S-adenosyl methionine (SAM) levels and the H3K27me3 repressive state. NNMT consumes SAM in naive cells, making it unavailable for histone methylation that represses Wnt and activates the HIF pathway in primed hESCs. These data support the hypothesis that the metabolome regulates the epigenetic landscape of the earliest steps in human development.
Pluripotent stem cells are able to self-renew and have the capacity to regenerate all tissues in the body. These cells hold promise for understanding early human development as well as developing therapies in regenerative medicine. Recent findings have revealed that pluripotency does not represent a single defined state; diverse states of pluripotency, with differences in measurable characteristics relating to gene expression, epigenetics and cellular phenotype, provide an experimental system for studying potential key regulators that constrain or expand the developmental capacity of pluripotent cells [1] [2] [3] [4] . Two stable pluripotent states have been derived in the mouse, and now in humans; preimplantation naive and postimplantation primed embryonic stem cell (ESC) states [5] [6] [7] [8] [9] [10] [11] [12] . As naive, preimplantation human ESCs (hESCs) show higher developmental potential than postimplantation, primed hESCs (refs 8,12) , it is critical to understand the key molecular differences between these pluripotent cell types.
Metabolic signatures are highly characteristic for a cell and may act as a leading cause for cell fate changes [13] [14] [15] [16] [17] [18] [19] [20] . Recent data have shown that pluripotent stem cells have a unique metabolic pattern. The naiveto-primed mouse ESC (mESC) transition accompanies a pronounced metabolic switch from a bivalent to a highly glycolytic state 20 . However, the primed state of inert mitochondria rapidly changes to highly respiring mitochondria during further differentiation. It is not yet understood how and why the pluripotent cells enter the highly glycolytic, metabolically cancer-like (Warburg effect) state and how a differentiating cell leaves this state.
In mESCs, the metabolism of threonine and that of S-adenosyl methionine (SAM) are coupled, resulting in regulation of histone methylation marks 21 . Methionine and SAM are also required for the self-renewal of hESCs, because depletion of SAM leads to reduced H3K4me3 marks and defects in maintenance of the hESC state 22 COX3  COX6B1  COX6C  COX7A2  COX4I1  COX6A2   COX11  COX7A1   COX10  COX7A2L  COX18  COX15  COX19  COX6B2  COX6A1  COX7C  COX8A  COX17  COX16  COX8C  COX412 Theunissen et al. 10 naive
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Theunissen et al. 10 PC2   PTPRZ1  USP44  GRPR  NLGN4X LECT1  FZD7   DUSP6  BEX1  STC1  KIF1A   SALL2   IDO1   NELL2  CRABP1   LCK   MFGE8  SFRP1 MAP7  SLCA73  HAPLN3  CLDN3 ZDHHC22   GPR176   DNMT3B   LDHA  JARID2  WNT3A   HIGDA1   COX5B  COX7B   NNMT   WNT5A  WNT10B   WNT8A T   WNT5B   WNT9A  KLF4  DPPA3   DPPA5   NLRP7   ALPPL2   KHDC3L   FGF4  ZYG11A  GDE3  CHST2   MT1E   NODAL  HPGD  CDX1  HAND1  MXL1  APLNR Normalized OCR (pmol min -1 ) Oligo FCCP Anti/Rot Figure 1 Naive and primed ESCs are metabolically different. (a) Principal component analysis (PCA) of RNA-seq data from this study (Elf1, H1 4iLIF, Lis1, H1) and other studies 6, 9, 46, 47 (Finkbeiner data can be accessed at ArrayExpress, accession number E-MTAB-3158). ComBat was applied on the combined RNA-seq data set. (b) Genes contributing to principal components separating primed versus naive hESCs. The size of the dots is proportional to the square of the first principal component (PC1) value. Top contributing genes are darker. (c) Metabolic profile of naive (Elf1 and H1 4iLIF) and primed (H1) hESCs. A trace of oxygen consumption rate (OCR) changes in response to oligomycin, FCCP and antimycin/rotenone is shown under a MitoStress protocol (s.e.m., n = 6 biological replicates). (d) Primed hESCs (H7 and H1) have reduced OCR changes in response to FCCP compared with naive hESCs (Elf1 and H1 4iLIF), n = 18 (H1, H1 4iLIF) or 24 (Elf1 and H7) biological replicates; s.e.m.; P = 0.122 for H1 4iLIF versus Elf1, P = 0.0001 for H1 versus Elf1, P = 0.0014 for H7 versus Elf1; twotailed t-test. NS, not significant. (e,f) Transition of naive hESCs Elf1 (e) and WIN1 (f) towards a more primed state by culture in activin-A-FGF (AF) media reduced OCR changes in response to FCCP after 1 to 3 days (D0 to D3) (n = 29 for Elf1 AF D1, n = 20 for Elf1 AF D2, n = 28 for Elf1 AF D3, n = 33 for Elf1, n = 18 for WIN1 and WIN1 AF; s.e.m.; P = 0.0013 for Elf1 AF D1 versus Elf1, P < 0.001 for Elf1 AF D2 versus Elf1, Elf1 AF D3 versus Elf1 and WIN1 AF versus WIN1; two-tailed t-test).
(g) Heatmap log 2 fold expression change of mitochondrial complex genes between primed and naive stages 10 . (h,i) Naive hESCs (Elf1) and primed hESCs (Elf1 AF) have similar mitochondrial DNA copy number (h, n = 3) and mitochondrial mutation frequencies (i, n = 3). s.e.m.; P = 0.7802 (h), P = 0.37 and 0.6 (i); two-tailed t-test. (j) HIF1α protein is stabilized in primed hESCs (H7 and Elf1 AF). (k) Proteomic workflow used to identify differentially regulated protein expression in primed versus naive hESCs. (l) Volcano plot of differentially expressed proteins in primed hESCs (green, Elf1 AF) versus naive cells (blue, Elf1). Significant hits are shown (false discovery rate (FDR) < 0.05). Proteins were quantified by nano-LC-MS/MS on a Fusion Orbitrap. (m) JARID2 and LDHA proteins are upregulated in primed hESCs (Elf1 AF and H7) compared with naive hESCs (Elf1), as revealed by western blot analysis. Unprocessed original scans of blots are shown in Supplementary Fig. 9 . For raw data, see Supplementary  Table 4 . n represents the number of biological replicates. * * P < 0.01; * * * P < 0.001.
therefore is shown to be a key regulator for maintaining the ESC undifferentiated state and regulating their differentiation. However, little is known about SAM levels or its regulation during the transition between naive and primed human embryonic states. Recent derivation of naive hESCs allows a deeper analysis of the human naive-toprimed transition [6] [7] [8] [9] [10] [11] [12] . These studies have already revealed that the epigenetic landscape changes from the naive to primed state through increased H3K27me3 repressive methylation marks. However, the regulation of this process or the metabolomics of this transition have not been dissected. We now show that the upregulation of H3K27me3 repressive epigenetic marks during the naive-to-primed hESC transition is controlled by the metabolic enzyme nicotinamide N -methyltransferase (NNMT). Knockdown of NNMT in naive hESCs increased H3K27me3 repressive marks in developmental as well as key metabolic genes that regulate the metabolic switch in naive-to-primed transition. CRISPR-Cas9-based NNMT KO naive hESC lines show upregulation of SAM, H3K27me3 marks, hypoxia-inducible factor (HIF) activation, Wnt repression and a general gene expression shift towards the primed stage. These data show that NNMT consumes SAM in naive cells, making it unavailable for histone methylation. Histone methylation further regulates the key signalling pathways important for the metabolic changes that are necessary for early human development.
RESULTS
A pronounced metabolic switch occurs in mESCs between the preimplantation (naive) and postimplantation (primed) states 20 . The human naive counterpart has been recently toggled or derived from embryos. Principal component analysis (PCA) of the expression signatures of these new cell types confirmed that all derived naive hESCs are in a significantly earlier stage than primed hESCs (Fig. 1a,b and Supplementary Fig. 1A-C and Supplementary Table 1A ) 6, [8] [9] [10] 23 . To assess the metabolic profiles of the naive and primed hESCs, we analysed the cells' oxygen consumption rates (OCR) using a Seahorse extracellular flux analyser. As seen previously in mESCs (ref. 20) , we detected a significant increase in OCR after FCCP injection in the newly derived naive hESCs (Elf1; ref. 12; WIN1; ref. 10) whereas a much smaller increase was observed in primed hESCs (H1, H7) or cells transitioning to the primed state (Elf1 AF, WIN1 AF; (Fig. 1c-f and Supplementary  Fig. 1E -I). Likewise, cells 'toggled' back to a more naive state (H1 2iF (ref. 12), H1 4iLIF) showed increased OCR in response to FCCP to a level similar to mESCs ( Fig. 1a,c,d and Supplementary Fig. 1G ,J-K). These results indicate that the primed hESCs have a lower mitochondrial respiration capacity than naive hESCs.
The higher mitochondrial capacity of naive hESCs (Elf1) reflects neither more mature mitochondria 12 , nor an increase in mitochondrial DNA (mtDNA) copy number compared to primed hESCs (Elf1 AF, H7, H1; Fig. 1h and Supplementary Fig. 1L ,M). Further, no obvious increase in mtDNA mutation frequency was detected in primed compared to naive hESCs ( Fig. 1i and Supplementary Fig. 1N ,O), suggesting that reduction of oxidative respiration in primed hESCs is not caused by a deteriorating mitochondrial genome. However, consistent with the mouse data, RNA-seq data from our study and microarray or RNA-seq data from other studies 3, 6, [8] [9] [10] showed that expression of most mitochondrial electron transport chain complex IV (cytochrome c oxidase (COX)) genes is significantly downregulated in the primed state compared with the naive state ( Fig. 1g and Supplementary Table 1B-D) . Also, consistent with the mouse data 20 , HIF1α is stabilized in primed but not in naive hESCs ( Fig. 1j ), correlating with a significant change in expression of prolyl hydroxylase domain-containing protein 2, PHD2 (EGLN1), the primary regulator of HIF1α steady-state levels 24, 25 ( Supplementary  Table 1B ). Further support for HIF1α stabilization and activity at the primed state comes from our proteomic analysis revealing a significant increase in the protein expression of the HIF targets Ldha and Jarid2 at the primed hESC state (Elf1 AF compared with Elf1; Fig. 1k ,l and Supplementary Table 1E and Supplementary Fig. 1P , validation in Fig. 1m ).
Differential metabolites between naive and primed embryonic stem cells
To search for critical metabolites that control the metabolic transitions between naive and primed mESCs and hESCs, we performed metabolic profiling using gas chromatography time of flight (GC-TOF), liquid chromatography quadrupole time of flight (LC-QTOF) and liquid chromatography triple quadrupole (LC-QQQ) mass spectrometry (MS) analysis ( Fig. 2a and Supplementary Table 1F -L).
PCA of the metabolite data reveals a difference in metabolite profiles between naive and primed cells, regardless of species (Fig. 2b-f and Supplementary Fig. 2 ). Multiple naive and primed cell lines from human and mouse separated clearly by naive versus primed state on the basis of the PCA plot of GC metabolomics data ( Fig. 2b ,d-f and Supplementary Fig. 2A -C). Stearic acid and cholesterol are the metabolites that contribute the most to the separation within the first PC, indicating that when ESCs transition from the naive to the primed state, a major switch occurs in the lipid metabolism. A similar trend of naive and primed ESC separation is observed in PCA plots of the LC metabolomics data ( Fig. 2c and Supplementary Fig. 2D ). However, H1 2iF, which is a primed cell line, 'toggled' towards the naive state, and Elf1, the naive hESC line, clustered midway between the mouse naive cell line (R1) and primed cell lines (R1 AF, EpiSC, Elf1 AF, H7 and H1) in LC analysis, suggesting that H1 2iF and Elf1 have not reached the same naive state as observed in mouse cells, with respect to lipid signature ( Fig. 2c and Supplementary Fig. 2D ).
In addition, targeted analysis of metabolites was performed using LC-QQQ MS with naive Elf1 and primed H1 hESCs ( Fig. 2g and Supplementary Table 1H ,I) and using GC-TOF with naive Elf1 and primed Elf1 AF ( Supplementary Fig. 2B and Supplementary Table 1J ). Metabolites upregulated in the primed state include fructose(1,6/2,6)bisphosphate (F16BP or F26BP), lactate, methionine, nicotinamide and kynurenine ( Fig. 2f,g and Supplementary Fig. 2B ). Upregulation of F16BP is in concord with highly active glycolysis; however, phosphoenolpyruvate (PEP), a downstream metabolite of F16BP, does not increase in primed hESCs ( Fig. 2h ,i). Intermediates before PEP can be conserved for biosynthetic purposes: 3-phosphoglycerate can be diverted to serine and glycine synthesis, which can supply one-carbon units to multiple methylation reactions; dihydroxyacetone phosphate (DHAP) can be converted to glycerol, which serves as the backbone of glycerolipids. Therefore, we tested potential changes in lipid and fatty acid metabolism and amino acid pathways ( Fig. 2h ). Differential fatty acid metabolism in naive and primed ESCs Further lipid analysis was performed using a LC-QTOF instrument on naive Elf1 and primed H1 cells ( Supplementary Table 1K ) as well as non-targeted LC-QTOF analysis on Elf1, Elf1 AF, R1 and mEpi ESCs ( Supplementary Table 1L ). For 119 lipidomic features with identified molecular formulae and structures, lipids more abundant in H1 have higher numbers of carbons (Wilcoxon rank sum test P value 4.30 × 10 −4 , Fig. 3a ). For 320 features with just identified mass, lipids more abundant in H1 are heavier (P value = 1.66 × 10 −10 , Fig. 3b ). Non-targeted LC-QTOF also showed that lipids more abundant in mEpi than in R1 have a significantly higher number of carbons (P value = 0.012, Supplementary Fig. 3G ). When sorting on the basis of unsaturation, lipids more abundant in primed R1 AF have a higher number of double bonds than lipids more abundant in naive R1 (P value = 0.044, Fig. 3c ), which can also be observed in primed Elf1 AF compared with naive Elf1 (P value = 7.35 × 10 −5 , Supplementary Fig. 3F ).
In concordance with the significant increase in long-carbonchain lipids observed in primed mouse and human ESCs, we also detected a significant increase in accumulation of lipid droplets in Supplementary Table 1M ). (i) qPCR expression of hsa-miR-9 and hsa-miR-10a (predicted to target CPT1A and FASN, respectively). hsa-miR-10a is 34-fold higher, and hsa-miR-9 is 4fold lower in Elf1 versus H1 (n = 3, s.e.m.; miR-10a: P = 0.004, miR-9: P = 0.022; two-tailed t-test). (j-l) Seahorse palmitate assay shows that naive human and mouse ESCs use fatty acids as a source of energy. A trace of OCR changes after palmitate (PALM) or BSA vehicle addition, followed by ETO in hESCs (naive Elf1 and primed H7, j) and mESCs (naive R1 and primed EpiSCs, k). n = 4 for Elf1 BSA, R1 BSA, Epi BSA, n = 5 for Elf1 PALM, R1 PALM, Epi PALM, n = 6 for H7 BSA, H7 PALM; s.e.m. Changes after ETO injections were quantified in l (Elf1 BSA (n = 12), R1 BSA (n = 12), Epi BSA (n = 12), Elf1 PALM (n = 15), R1 PALM (n = 15), Epi PALM (n = 15), H7 BSA (n = 18), H7 PALM (n = 18), s.e.m.; naive hESCs: P = 0, 0096, primed hESCS: P = 0.354, naive mESCs: P = 0.03, primed mESCs: P = 0.88, two-tailed t-test). For raw data, see Supplementary Table 4 . n represents the number of biological replicates. * P < 0.05; * * P < 0.01. the primed state, as observed by Oil red O and BODIPY staining ( Fig. 3d ,e and Supplementary Fig. 3A,B ). These data indicate an increased synthesis and/or decreased beta-oxidation in primed cells. Interestingly, several of the enzymes involved in fatty acid transport into the mitochondria and fatty acid beta-oxidation are significantly downregulated in primed hESCs, as well as in the mouse in vivo postimplantation state ( Supplementary Fig. 3H (b) IDO1 is highly expressed in primed hESCs as compared with naive hESCs (qPCR, n = 3 for H1 4iLIF, Elf1 AF, n = 4 for H1 2iF, H1, H7, n = 5 for Elf1 2iLIF; s.e.m.; * * * P < 0.001; two-tailed t-test). (c) The kynurenine versus tryptophan ratio is higher in primed than naive hESCs, as detected by targeted (n = 6) and non-targeted (HILIC: n = 4, QQQ n = 3) mass spectrometry. (s.e.m.; * P < 0.05, * * P < 0.01, * * * P < 0.001; one-tailed t-test.) (d) Model of SAM pathway and NNMT. Metabolites in red are upregulated in primed hESCs. Metabolites and enzymes in blue are upregulated in naive hESCs. (e) Volcano plot of RNA-seq data from naive hESCs (Elf1) and primed hESCs (H1). Genes with greater than twofold change and FDR < 0.05 are coloured. NNMT and IDO1 are among the most differentially expressed genes. (f) NNMT is highly upregulated in naive hESCs compared with primed hESCs (qPCR). Numbers indicate fold changes of naive hESCs compared with H1 and H7 primed hESCs. (n = 3 for WIN1, H7 5iLAF, Elf1, H1 4iLIF, H1 4iLTF, Lis1, WIN1F, Elf1 AF, n = 4 for WIN1 5iLA, H1 2iF, H1, H7, n = 5 for H7 5iLIF; s.e.m.; * * * P < 0.001; two-tailed t-test.) (g) Naive hESCs (n = 4 each) have higher amounts of 1-MNA than primed hESCs (n = 4 for H1, n = 6 for WIN1 TeSR, Elf1 AF) (s.e.m., * * * P < 0.001, two-tailed t-test). 1-MNA was not detected in the Elf1 CRISPR-Cas9 KO mutant of NNMT (gNNMT 7.2.1, n = 6; gNNMT 6.2.4, n = 6). (h) SAM levels are higher in primed hESCs (H1 n = 4, Elf1 AF n = 6) than in naive hESCs (Elf1 n = 4) (s.e.m.; P = 0.0089 for Elf1 AF versus Elf1, P = 0.0376 for H1 versus Elf1; two-tailed t-test).
(i,j) SAM induces a 'primed-like' metabolic profile in naive hESCs. Addition of SAM (500 µM) for 5 h in media without methionine reduces OCR changes in response to FCCP in naive hESCs (WIN1). A Seahorse trace is shown in i (n = 6; s.e.m). OCR changes after FCCP are quantified in j (n = 23; s.e.m.; P = 0.017). (k) Overexpression of NNMT delays the metabolic transition from naive to primed (n = 4; s.e.m.; P = 0.028, two-tailed t-test). For raw data and exact P values, see Supplementary Table 4 . n represents the number of biological replicates. * P < 0.05; * * P < 0.01; * * * P < 0.001. the rate-limiting fatty acid transporter CPT1A is downregulated in both mouse in vivo postimplantation and human primed ESC state compared with all analysed naive states (Fig. 3f ). The decrease in CPT1A expression in the primed state could be due to increased H3K27me3 and decreased H3K4me3 and H3K27ac marks observed in the CPT1A promoter in primed hESCs ( Fig. 3g and Supplementary  Fig. 3C ) 6, 8, 12 . Several of the microRNAs (miRNAs) predicted to target CPT1A and other enzymes involved in beta-oxidation are upregulated in primed hESCs (for example, miR-9, miR-33a-3p, Fig. 3h and Supplementary Table 1M ). Moreover, miRNAs predicted by Targetscan and miRTarBase to target enzymes involved in fatty acid synthesis were downregulated in primed cells (for example, miR-10a and miR-193, Fig. 3h ). Concomitantly, key fatty acid synthesis genes were up in primed H1 hESCs compared with the naive Elf1 state (SLC25A1, ACLY, ACACA, FASN and SREBP-1c; Supplementary  Fig. 3D ). We further validated some of the miRNAs by qPCR analysis and showed that miR-9, predicted to target CPT1A, was upregulated, whereas miR-10a, predicted to target SREBP-1c (a regulator of fatty acid and cholesterol synthesis), was downregulated in the human primed state ( Fig. 3i) .
To test the level of fatty acid beta-oxidation in naive and primed human and mouse ESCs, we performed a palmitate-oxidation assay in the Seahorse metabolic flux analyser 26 . Importantly, both mouse and human naive ESCs were capable of using palmitate as an energy source, whereas primed mouse or human ESCs were not ( Fig. 3j-l and Supplementary Fig. 3E ). This result suggests that primed human and mouse ESCs are not capable of significant beta-oxidation and, in combination with increased fatty acid synthesis, may explain the accumulation of lipids observed in this state (Fig. 3d ,e and Supplementary Fig. 3a,b ).
Differential amino acid metabolism in naive and primed ESCs
In addition to glycolysis and fatty acid metabolism, primed cells show changes in amino acid metabolism pathways. In primed versus naive hESCs we observed a large enrichment of the tryptophan degradation product kynurenine, which can act as a ligand for the nuclear receptor AHR (Fig. 4a ,c) 27 . Interestingly, tryptophan is shown to be critical for primed hESC growth 22 . Accordingly, RNA-seq and qPCR data show a large increase of the tryptophan-metabolizing enzyme IDO1 in primed hESCs compared with naive hESCs and in vivo 8-cell human embryos 23 (Figs 1b and 4b,e and Supplementary Fig. 4A ). IDO1 levels quickly drop during differentiation, indicating a specific function for IDO1 in the primed state 12, 28, 29 ( Supplementary Fig. 4B ,C and Supplementary Table 1N ).
Interestingly, a strong upregulation of 1-methylnicotinamide (1-MNA), a product of NNMT activity, was observed in all naive compared with primed hESCs (Fig. 4g ). Methionine and nicotinamide downregulation along with 1-MNA upregulation in the naive state correlates with upregulation of NNMT, shown previously to create a metabolic methyl sink, thereby promoting epigenetic remodelling in cancer 28 (Fig. 4d-g and Supplementary Fig. 4G ). Primed hESCs show an increase in SAM levels compared with the naive state ( Fig. 4h and Supplementary Fig. 4H and Supplementary Table 1O ). The increase in SAM correlates with the sharp decrease in NNMT enzyme levels observed in primed hESCs ( Fig. 4h ,e,f) 6, 8, 11 , suggesting that SAM levels may be reduced in the naive state by high NNMT activity. Further, significant expression changes of NNMT among various tissues reveal that NNMT is dynamically regulated during development and suggest that NNMT might act as regulator of SAM levels also in a developmental context, not only in cancer 30 (Supplementary Fig. 4D-F and  Supplementary Table 1N ). Accordingly, we show that high levels of SAM induce a primed-like metabolic profile in naive hESCs whereas overexpression of NNMT, but not the mutated form of NNMT, delays the naive-to-primed hESC metabolic switch ( Fig. 4h-k and Supplementary Fig. 4I ).
NNMT regulates repressive histone modifications
Reduction of NNMT levels during the naive-to-primed transition correlates with a significant increase in SAM levels and in H3K27me3 histone methylation marks in 648 developmentally regulated genes 6, 8, 10, 12 (Fig. 5a ). Moreover, western blot analysis revealed an overall increase of H3K27me3 and H3K9me3 marks in primed hESCs compared with naive hESCs, whereas the H3K9 and H3K14 acetylation marks remained unchanged ( Fig. 5b and Supplementary  Fig. 5H ). ChIP-seq analysis of other marks (H3K4me1, H3K4me3 and H3K27ac) did not show a significant change between primed and naive hESCs ( Supplementary Fig. 5A -G) 6, 8 . RNA-seq analysis of histone methyltransferases and histone demethylases involved in H3K27 and H3K9 methyl marks did not show changes in expression levels that could explain the significant increase in repressive methylation marks observed at the primed state ( Supplementary  Fig. 5I-J ). Furthermore, we showed by western blot analysis that the protein levels of the polycomb repressive complex 2 (PRC2) regulator, EED, are not increased in the primed state compared to the naive state ( Fig. 5b ).
Overexpression of NNMT in primed cells reduced H3K27me3 marks ( Supplementary Fig. 4I ). The direct reduction of NNMT levels in naive hESCs significantly reduced the enzymatic product, 1-MNA, reduced naive hESC enriched microRNAs and increased H3K27me3 and H3K9me3 marks, as analysed by western blots, whereas H3K9 and H3K14 acetylation marks did not change (Fig. 5c,d and Supplementary  Fig. 5K ,L). RNA-seq analysis of NNMT knockdown identified a significant overlap between genes changed in NNMT KD and the naive-to-primed transition (Fig. 5e ). In particular, the most significant overlap is observed between genes upregulated by NNMT knockdown and genes expressed higher in Elf1 AF versus Elf1. Therefore, on the basis of transcriptome signatures, NNMT knockdown samples do not only show increased repressive H3K27me3 marks but are also moving towards the primed state.
To analyse the early NNMT-responsive genes for H3K27me3 marks, we altered the NNMT regulator, LIF-STAT pathway. In naive hESCs LIF activates STAT3 (ref. 31 ). Activated STAT was previously shown to bind the NNMT promoter and activate its transcription 32 . H1 toggled to a more naive state using 2iF (ref. 12) without external LIF addition also has a high level of NNMT ( Fig. 4f ) and activated LIF-STAT pathway, suggesting that the LIF pathway is endogenously activated in the naive hESC state ( Supplementary Fig. 5M ). We show that treating naive hESCs with a STAT3 inhibitor affects NNMT expression and the repressive histone methylation pattern. qPCR analysis showed a reduction of NNMT expression in Elf1 cells as early as 6 h after STAT3 inhibitor addition ( Supplementary  Fig. 5N ). Importantly, reduction of NNMT in naive hESCs by STAT3 Supplementary Fig. 9 . For raw data, see Supplementary Table 4 . n represents the number of biological replicates.
* P < 0.05; * * * P < 0.001.
inhibitor also increased H3K27me3 and H3K9me3 marks, as shown by western blot analysis ( Fig. 5f ). We characterized H3K27me3 in naive hESCs by ChIP-seq analysis and observed a significant increase in H3K27me3 marks at promoters after 6 h STAT3 inhibitor treatment ( Fig. 5g and Supplementary Table 1P ,Q). Interestingly, more than 25% (313 genes) of genes with primed-enriched H3K27me3 marks already showed increased H3K27me3 marks after 6 h STAT3 inhibitor treatment ( Fig. 5h and Supplementary Table 1R ). Windowed heatmap and average profile of ChIP-seq signal revealed a marked increase in H3K27me3 marks close to the transcription start site of these 313 genes in the naive-to-primed transition as well as after 6 h STAT3 inhibitor treatment 5, 9 (Fig. 5i ,j). Among these genes are components of the Wnt pathway and regulators of HIF ( Fig. 5h and Supplementary Table 1R ). were quantified (n = 8 for Elf1, n = 6 for Elf1+IWP2, WIN1, WIN1+IWP2, WIN1 AF, n = 7 for WIN1 AF+IWP2; s.e.m.; P = 0.0009 for Elf1+IWP2 versus Elf1, P = 0.0084 for WIN1+IWP2 versus WIN1, P = 0.0006 for WIN1 AF+IWP2 versus WIN1 AF; two-tailed t-test). (e) Wnt inhibition by IWP2 (2 µM, 72 h) downregulates NNMT (normalized to ACTB) and miR-372 (normalized to RNU66) expression in naive hESCs (Elf1) as shown by qPCR analysis. (n = 3; s.e.m.; P = 0.04 for miR-372, P = 6.44 × 10 −6 for NNMT; one-tailed t-test.) (f) Model of self-reinforcing loop between WNT and NNMT in primed hESCs. For raw data, see Supplementary Table 4 . n represents the number of biological replicates. * P < 0.05; * * P < 0.01; * * * P < 0.001.
Most Wnt ligands and target genes are downregulated in primed compared with naive hESCs, suggesting that the Wnt pathway might be inactivated during the naive-to-primed transition ( Fig. 6a and Supplementary Fig. 6A -D and Fig. 1b ,l, Vime; ref. 33 ). Previous studies have revealed that in human and mouse primed ESCs the Wnt pathway is not significantly activated and forced activation of the pathway leads to differentiation 34, 35 . We now show using a Wnt-pathway activity reporter 34 that although the reporter is not activated in primed hESCs, strong activation is observed in naive hESCs ( Fig. 6b and Supplementary Fig. 6F ). We furthermore show that the Wnt activity in naive hESCs is dependent on β-catenin because short interfering RNA (siRNA; β-cat) or XAV939 treatment markedly downregulated the reporter activity ( Fig. 6c and Supplementary Fig. 6E ). In addition, the Wnt ligand is produced by the naive hESCs because IWP2, an inhibitor that represses Wnt palmitylation, also represses the reporter activity in naive cells (Fig. 6c ). Inhibition of Wnt in naive hESCs reduces expression of the naive hESC enriched markers, NNMT and microRNA miR-372 (ref. 12) , and accelerates the transition towards the primed metabolic state (Fig. 6d-f and Supplementary Fig. 6G ). These data reveal that the robust Wnt activity in naive hESCs is among the earliest responders to the repressive H3K27me3 marks during naive-to-primed hESC transition. (g) qPCR analysis of hESCs transitioning to primed reveals that naive markers (DNMT3L and NNMT) are still expressed higher in Elf1 HIF1α CRISPR-Cas9 KO cells compared with wild-type Elf1, whereas primed marker IDO1 and HIF target genes (PDK1 and VEGFA) are downregulated (n = 3; s.e.m.; P = 0.024 for DNMT3L, P = 0.0005 for NNMT, P = 0.001 for IDO1, P = 0.12 for PDK1, P = 0.004 for VEGFA; two-tailed t-test). (h) KO of HIF1α prevents the metabolic switch occurring during the transition of hESCs from the naive to the primed state as shown by measuring OCR after FCCP addition using Seahorse. n = 3 for gHIF1 6.3.1 2iLIF and AF and n = 4 for Elf1 iCas9 and gHIF1 6.2.1 2iLIF and AF; s.e.m.; P = 0.0117 for gHIF1 6.2.1 versus Elf1 iCas9, P = 0.0032 for gHIF1 6.3.1 versus Elf1 iCas9; twotailed t-test. Unprocessed original scans of blots are shown in Supplementary  Fig. 9 . For raw data, see Supplementary Table 4 . n represents the number of biological replicates. * P < 0.05; * * P < 0.01; * * * P < 0.001. Supplementary Fig. 9 . For raw data, see Supplementary Table 4 . n represents the number of biological replicates. * P < 0.05; * * * P < 0.001.
A R T I C L E S
A significant increase of H3K27me3 marks was observed in the metabolic gene, prolyl hydroxylase 2 (EGLN1), ECHS1, HIGD1 and miR-193 (Figs 5h and 7a) promoters in the primed state as well as in STAT3-inhibitor-treated Elf1 cells, versus the naive state ( Supplementary Table 1R ). The increased repressive H3K27me3 mark in the EGLN1 promoter correlated with the observed reduced gene expression in the primed state (Fig. 7a ). As EGLN1 induces VHL and ubiquitylation-dependent HIF1α degradation, its repression in the primed state (Fig. 7a ) could cause HIF1α stabilization in the primed hESC stage (Figs 7b and 1j ). Furthermore, ectopic HIF1α stabilization accelerates primed hESC markers ( Supplementary Fig. 7A-C) . To test whether HIF1α KO affects the naive-to-primed transition in hESCs, we generated CRISPR-Cas9-based HIF1α KO lines and analysed their capacity to develop from the preimplantation to postimplantation stage in human development (Fig. 7c-f and Supplementary Fig. 7D ). Importantly, the gene expression analysis revealed that naive markers were upregulated and primed markers downregulated, suggesting that HIF1α KO naive hESCs are not capable of transitioning to the primed stage ( Fig. 7g ). Furthermore, Seahorse flux analysis showed that HIF1α KO hESCs do not exhibit an OCR reduction, suggesting that they are defective in the metabolic switch normally observed in the naive-toprimed hESC transition ( Fig. 7h and Supplementary Fig. 7E ). These data show that HIF1α is required for naive-to-primed hESC transition.
To validate the NNMT-based regulation of the Wnt and HIF pathways in the naive-to-primed transition (Fig. 5h) we generated CRISPR-Cas9-based NNMT KO mutant lines that lack NNMT enzymatic activity as shown by a lack of 1-MNA production and an increase in SAM levels (Fig. 8a-d and Supplementary Fig. 8A-D,G and Fig. 4g ). As observed with NNMT KD experiments (Fig. 5d ), NNMT KO lines showed a significant increase in H3K27me3 marks (Fig. 8e ). This epigenetic modification was accompanied by pronounced stabilization of the HIF1α protein and downregulation of the naive hESC marker DNMT3L (Fig. 8e,f) . Furthermore, genome-wide RNA sequencing results revealed that the NNMT KO line 7-2-1 shows upregulation of HIF pathway genes, downregulation of the Wnt pathway ( Fig. 8g ) and a genome-wide gene expression signature indicative of a general shift towards the primed stage, even in the presence of primed stage inhibitors (2iLIF; Fig. 8h ,i and Supplementary Fig. 8E-F,H) . Downregulation was also observed among a significant fraction of the 313 genes with increased repressive H3K27me3 marks in the primed state and after STAT3 inhibitor treatment (hypergeometric test P value < 0.0036). In summary, these data show that NNMT affects the naive-to-primed hESC transition through epigenetic alterations that repress the Wnt pathway and activate the HIF pathway.
DISCUSSION
We show that human naive and primed ESCs exhibit distinct metabolic profiles and the switch between these metabolic states is regulated by NNMT, which controls the amount of SAM available for PRC2-dependent H3K27me3 histone methylation. Repressive histone methylation then controls the primed hESC specific metabolism through the Wnt and HIF pathways (Fig. 8j) . The naive-to-primed hESC transition shows a reduction in Wnt signalling, electron transport chain activity, and fatty acid beta-oxidation and an increase in mechanisms involved in lipid biosynthesis and HIF1α stabilization. In naive hESCs NNMT and its enzymatic product 1-MNA are highly upregulated, whereas the substrates nicotinamide and SAM are downregulated, correlating with reduced H3K27me3 marks. Inhibition of the NNMT regulator, STAT3, in naive hESCs increases H3K27me3 repressive marks in developmental and metabolic genes, including Wnt signalling and the HIF1 repressor, prolyl hydroxylase EGLN1. Further validations using Wnt pathway inhibitors reveal that Wnt activity is critical for the naive state. The HIF1α KO mutant line generated by the CRISPR-Cas9 system is incapable of the naive-toprimed metabolic and fate switch, showing that HIF1α is required for the naive-to-primed hESC transition. NNMT KO naive hESC lines show increased H3K27me3 marks, HIF1α stabilization and Wnt ligand reduction, all indications of a transition towards the primed state, even in the presence of naive state stabilizers (MEK and GSK3 inhibitors and LIF). These data show that NNMT consumes SAM in naive cells, making it unavailable for histone methylation that represses the Wnt pathway and electron transport chain activity and activates the HIF pathway and lipid synthesis, facilitating the metabolic switch in the naive-to-primed hESC transition (Fig. 8j ). Therefore, differential metabolites between pluripotent states control epigenetic dynamics and signalling.
Primed ESCs are dependent on glycolysis 14, 17, [36] [37] [38] [39] . We now show that although early glycolysis metabolites are upregulated, the downstream metabolites are downregulated in primed-state hESCs, suggesting that metabolites are being channelled off to increase the amount of glycerol backbone available for biosynthesis of lipids in primed cells, or for the one-carbon cycle for methylation reactions by SAM. SAM can also be regulated by NNMT, whose enzymatic product, 1-MNA is markedly increased in naive versus primed hESCs. As NNMT is considered to create a methyl sink 28 , reduction of NNMT in primed hESCs can make SAM available as a substrate for DNA and histone methylation. We show that a difference in SAM levels between naive and primed hESCs correlates with pronounced changes in H3K27me3 marks 6, 8, [10] [11] [12] and reveal NNMT as a key regulator of these changes. Although previous studies have shown SAM-dependent regulation of histone methylation in stable primed hESCs, the effect was mainly observed in H3K4me3, not in H3K27me3 marks 22 . It is plausible that H3K27me3 marks, once established, are less dynamic in primed hESCs than H3K4me3 marks 40 .
Although H3K27me3 marks are reduced in naive compared with primed hESCs, the enzymes required for this methylation (EZH2 and EED) are not downregulated. We now show that high NNMT activity in naive hESCs sequesters the methylation substrate, SAM, thereby repressing H3K27me3 marks. Furthermore, the PRC2-recruiting protein Jarid2 is upregulated in primed hESCs compared with naive, which may give further specificity to PRC2 action in the naive-toprimed hESC transition 41, 42 (Figs 1b,l,m and 8j ).
In this study we show a direct impact of SAM levels and NNMT function on histone marks in naive hESCs, revealing that changes in the metabolic profile of hESCs shape the epigenetic landscape during development. Although previous studies have revealed the importance of Wnt and HIF pathways in naive or primed pluripotent stem cells 35, 39, [43] [44] [45] , we now show that these pathways are regulated by metabolite levels. We propose that the availability of SAM triggers the cascade by activating PRC2 and thereby increasing repressive H3K27me3 epigenetic marks in the promoters of key regulators of the naive-to-primed transition, HIF repressor and Wnt ligands ( Fig. 8j) . These studies pave the way for further understanding and use of metabolite-specific molecular mechanisms for cell fate changes in general.
METHODS
Methods and any associated references are available in the online version of the paper. 

Culture of primed and naive embryonic stem cells.
Primed hESCs (H1 (WA-01, WiCell) and H7 (WA-07, WiCell)) and naive hESCs (Elf1 (NIHhESC-12-0156, University of Washington), WIN1 (NIHhESC-14-0299, MIT)) and Lis1 (ref. 8) (Weizmann Institute of Science) were cultured as previously described 10, 12 . Briefly, the cells were cultured on a feeder layer of irradiated primary mouse embryonic fibroblasts (MEFs) in hESC media ( Supplementary Table 3 ). One passage before the experiments, the cells were transferred to growth-factor-reduced Matrigel (Becton Dickinson) in MEF-conditioned media (CM). Reverse toggling of H1 and H7 cells was performed using supplemented media ( Supplementary Table 3 ). H1 cells were pushed towards a more naive state by culture in 4iLIF (modified from Gafni et al.: 1 µM GSK3 inhibitor (CHIR99021), 1 µM of MEK inhibitor (PD0325901), 5 µM JNK inhibitor (SP600125), 2 µM p38 inhibitor (BIRB796), 10 ng ml −1 human LIF, 5 ng ml −1 IGF and 10 ng ml −1 bFGF) for 3 passages ( Supplementary Fig. 1D ). In addition, human naive cells (Elf1 and WIN1) were pushed towards a more primed state by culturing them in either TeSR1 (STEMCELL Technologies), or bFGF (10 ng ml −1 ) with or without activin A (10 ng ml −1 ) for 3 passages (Elf1 AF, WIN1 AF, WIN1 F, WIN1 TeSR). Mouse ESCs (R1, EpiSC, R1 AF) were cultured as described in Supplementary Table 3 . All cells were grown at 37 • C, 5% CO 2 and 5% O 2 . Cells have been karyotyped by Diagnostic Cytogenetics, and were tested for mycoplasma detection using MycoAlert detection kit (Lonza). Mitochondrial DNA mutation frequency and copy number analysis. The DNA of Elf1 and H7 cells was isolated using DNAzol (Invitrogen). TaqMan primers were used to quantify mitochondrial and genomic DNA (Supplementary Table 2 ). The ratio of mtDNA to genomic DNA was determined using a standard curve for each primer. Each reaction contained 2 ng of DNA extract, 1× TaqMan Universal PCR Master Mix No AmpErase UNG, 500 nM of each primer, and 200 nM of the TaqMan probe. Using the 7300 real-time PCR system (Applied Biosystems), the reactions were amplified by incubation at 50 • C for 2 min, 95 • C for 10 min, and then 40 cycles of 15 s at 95 • C followed by 1 min at 60 • C where the intensity of fluorescence was measured.
OCR and ECAR measurement using
Naive hESCs (Elf1) and primed hESCs (H1 and Elf1 AF) were grown in triplicate for mutation analysis. Elf1 were analysed between passage 19 and 23, Elf1 AF were analysed at passage 25 and H1 at passage 65. All lines were grown on Matrigel for the last passage before analysis.
DNA was isolated from hESCs with the DNeasy Blood and Tissue Kit (QIAGEN). Rare mutation-bearing molecules were selectively enriched through endonucleolytic destruction of wild-type target sites by sequential additions of TaqI (New England Biolabs). Complete cleavage of wild-type TaqI sites was verified by PCR followed by restriction digest and gel electrophoresis. Reaction droplets were prepared as described previously 49 , with primers and probe sets specific to each target region (Supplementary Table 2 ). Fragments for point mutation detection and mtDNA copy number measurement were amplified as follows: 95 • C for 10 min, followed by 40 cycles of 94 • C for 30 s, and 60 • C for 1 min. For digital deletion detection, thermal cycling was as follows: 95 • C for 10 min, followed by 50 cycles of 94 • C for 30 s, and 63.5 • C for 2 min. The thermally cycled droplets were analysed by flow cytometry in a QX100 Droplet Digital Reader (Bio-Rad) for fluorescence analysis and quantification of mutation frequencies and mtDNA copy number, as described elsewhere 49 .
Proteomics. Naive hESCs (Elf1 2iLIF) and primed hESCs (Elf1 AF) were washed in 1×PBS and flash frozen. Cell pellets were lysed in 1 M urea, 50 mM ammonium bicarbonate, pH 7.8, and heated to 50 • C for 20 min. Normalized quantities of protein were reduced, alkylated, and digested overnight with trypsin. The resulting peptides were desalted on Waters Sep-Pak C18 cartridges. Peptides were measured by nano-LC-MS/MS on a Thermo Scientific Fusion Orbitrap. Peptides were separated by reverse-phase chromatography in a 180 min gradient (1-45% acetonitrile). The Fusion was operated in data-dependent mode with the following settings: 60,000 resolution, 400-1,600 m/z full scan, Top Speed 3 s, and an 1.8 m/z isolation window. Identification and label-free quantification of peptides was done with MaxQuant 1.5 (ref. 50) using a 1% false discovery rate (FDR) against the human Swiss-Prot/TrEMB database downloaded from Uniprot on 11 October 2013. We analysed two biological and three technical replicates per condition. Proteins that were significantly regulated between conditions were identified using a permutationbased t-test (S1, FDR 5%) in Perseus 1.4.1.3.
Non-targeted GC-TOF and LC-QTOF analysis for metabolites in mouse and human ESCs.
For the first set of experiments ( Fig. 2b-f ) 5-20 million cells per replicate (grown on 'ghost': irradiated MEFs lysed using a detergent solution 0.5% Triton and 0.034% (v/v) NH 4 OH (Sigma-Aldrich) to retain their extracellular matrix) were scraped in PBS, pelleted in 6 replicates per condition, and frozen at −80 • C. For the first set of experiments cells were thawed on ice and mixed with 2 ml of ice-cold degassed acetonitrile, and then vortexed for 20 s and sonicated for 5 min. One millilitre of material was taken and centrifuged for 5 min at 14,000 rcf (Eppendorf 5415D Centrifuge). Supernatant was divided into a 500 µl (GC-TOF) and a 250 µl (LC-QTOF) aliquot. Lyophilized aliquots were resuspended in 500 µl of 1:1 acetonitrile/H 2 O and centrifuged. Supernatants were lyophilized until analysis. For the second set of experiments cells were thawed on ice and extracted as previously reported 51 . The upper layer was used for LC-MS analysis and the bottom layer was used for GC-MS analysis; both layers were evaporated to dryness.
For mass spectrometry-based untargeted metabolomics, primary metabolites were derivatized in 40 µg ml −1 methoxyamine/pyridine and subsequently trimethylsilylated. GC-TOF MS analysis was performed as previously described 52, 53 using a Leco Pegasus IV time-of-flight MS coupled to an Agilent 6890 GC equipped with a 30-m-long 0.25 mm id Rtx5Sil-MS column and a Gerstel MPS2 automatic liner exchange system. Data were processed by ChromaTOF and BinBase filtering for metabolite identifications 52 .
LC-QTOF MS was used for analysis of complex lipids. For the first set of experiments, lyophilized material was redissolved in 100 µl initial LC gradient solvent and analysed within 24 h. HILIC and reversed-phase LC-QTOF analysis and data processing were performed as previously described 53 using an Agilent 1200 series HPLC equipped with either an Agilent Zorbax Eclipse Plus C18 2.1 × 150 mm column for reversed phase or a Waters 1.7 µm Acquity BEH HILIC 2.1 × 150 mm column. LC eluents were analysed with an Agilent 6530 accurate mass Q-TOF mass spectrometer. For the second set of experiments the lipid extracted phase was analysed as previously described 51 . Method blanks and human pooled plasma samples were used as QC controls. MZmine 2.10 was used to process the raw data and metabolites were reported when present in 50% of the samples in each group. Annotations were made based on an in-house accurate mass and retention time library created using LipidBlast, described previously 52, 54 .
Multivariate analysis of primed versus naive metabolomes. Metabolite measurements of known and unknown GC metabolites and known lipid metabolites (from ESI(+) and ESI(−) modes) were submitted using R to DeviumWeb (v 0.3.2; ref. 51) and normalized using unit norm normalization. O-PLS-DA, a multivariate classification model, was used to identify differences between primed and naive human and mouse cells. Robust model performance statistics were generated by 100 rounds of Monte Carlo cross-validation using training and testing compared with the permuted model (random chance).
LC-QTOF for Elf1 and H1 hESCs. For lipid extraction Elf1 and H1 cells were
grown on Matrigel for one passage. Cells were washed with PBS and 37 • C deionized water followed by the addition of 0.5 ml of a −75 • C solution of internal standards 52 and incubation on dry ice for 15 min. Cells were scraped into Eppendorf tubes and 1 ml of chloroform was added, followed by 15 min incubation on dry ice and spun for 5 min at 4 • C at 18,000 rcf (Beckman Coulter Microfuge 18), after which the lower phase was collected and stored at −80 • C.
LC-QTOF MS experiments were performed using an Agilent 1200 SL LC system coupled online with an Agilent 6520 Q-TOF mass spectrometer. Each sample (4 µl for positive ESI ionization, 8 µl for negative ESI ionization) was injected onto an Agilent Zorbax 300 SB-C8 column, which was heated to 50 • C.
Targeted LC-QQQ MS analysis for water-soluble metabolites. Targeted
LC-QQQ MS analysis was performed to detect a different set of water-soluble metabolites to complement the other non-targeted mass spectrometry experiments. Elf1 and H1 cells were grown on Matrigel for one passage, washed with PBS and ice-cold deionized water followed by the addition of a −75 • C 0.75 ml 9:1 methanol/chloroform solution. The plates were incubated on dry ice for 15 min before scraping into Eppendorf tubes, which were spun at 18,000g (Beckman Coulter Microfuge 18) for 5 min at 4 • C. All soluble extract was transferred into a new Eppendorf tube and vacuum dried. Samples were stored at −80 • C. DOI: 10.1038/ncb3264
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Dried samples were reconstituted in 200 µl 5 mM ammonium acetate in 40% water/60% acetonitrile + 0.2% acetic acid, and filtered through 0.45 µm PVDF filters (Phenomenex) before LC-MS analysis. LC-MS/MS was performed using an Agilent 1260 LC AB Sciex 5500 QQQ MS. Both chromatographic separations were performed in HILIC mode on two SeQuant ZIC-cHILIC columns. The mobile phase was composed of Solvents A (5 mM ammonium acetate in 90%H 2 O/10% acetonitrile + 0.2% acetic acid) and B (5 mM ammonium acetate in 90% acetonitrile/10% H 2 O + 0.2% acetic acid). The chromatographic separation, MS ionization and data acquisition were performed using an AB Sciex QTrap 5500 mass spectrometer equipped with an electrospray ionization (ESI) source. The instrument was controlled by Analyst 1.5 software. Targeted data acquisition was performed in multiple-reaction-monitoring (MRM) mode. The extracted MRM peaks were integrated using MultiQuant 2.1 software.
Targeted HILIC-QTOF mass spectrometry metabolite quantifications of methionine metabolites. Cells were grown on Matrigel for one passage, scraped and washed with PBS at room temperature, pelleted and flash frozen in liquid nitrogen. Samples were extracted by adding 1 ml cold 3:1 cold methanol/water to the cell pellet, vortexed, placed at −20 • C for 30 min, and centrifuged for 10 min at 14,000 rcf (Eppendorf 5415D Centrifuge). The supernatant was transferred and then centrifuged again, and then the supernatant was evaporated to dryness. Samples were resuspended in 80:20 acetonitrile/water containing Val-Try-Val. Standard curve dilutions for quantifications were prepared using a mixture of 1-methylnicotinamide HCl (1-MNA), S-methyl-5 -thioadenosine (MTA), S-adenosyl methionine (SAM), S-adenosyl homocysteine (SAH), methionine, kynurenine and tryptophan (Sigma).
Hydrophilic interaction chromatography (HILIC) analysis of standard curves and samples was performed using an Agilent 1290 Infinity Ultrahigh Pressure Liquid Chromatography stack equipped with an auto-sampler (4 • C) using 5 µl injections into an Acquity UPLC BEH Amide column (Waters Corporation). Mobile phases were prepared with 10 mM ammonium formate and 0.125% formic acid in either 100% LC-MS-grade water for mobile phase A or 95:5 acetonitrile/water for mobile phase B. Metabolites were detected and quantified by an Agilent 6530 accurate mass quadrupole time-of-flight (QTOF) mass spectrometer with a jet stream ESI source in positive ion mode. Mass calibration was maintained by constant reference ion infusion, with MS data collected at 4 spectra s −1 . Data files were analysed using Agilent Mass Hunter TOF Quantitative Analysis software. Peak filtering was performed manually to eliminate peaks with a signal-to-noise ratio of less than 3. Retention times and major adducts for each compound are as follows .768 min. Metabolites at undetectable levels and metabolites whose levels saturated the system were given the lowest and highest detectable values respectively in subsequent analysis.
Metabolite levels were sum-normalized for each sample using the methionine metabolite values (methionine, nicotinamide, MTA, 1-MNA, SAM and SAH). P values were calculated using a one-tailed t-test.
Transcriptomic data analysis. RNA-seq data processing was performed according to Takashima and colleagues 9 . Raw RNA-seq reads from this study and 3 other studies (Chan et al. 6 , Takashima et al. 9 and Yan et al. 23 ) were aligned to hg19/GRCh37 with STAR aligner 55 . Transcript quantification was performed with htseq-count from the HTSeq package 56 using GENCODE v15. Differential expression analysis was performed with DESeq after filtering out genes whose total read count across samples is below the 40th quantile of all genes.
Size factors used to normalize by library size were computed using the DESeq package 57 . Reads were further normalized by gene length.
Affymetrix Human Gene Array 1.0 ST arrays from Gafni et al. 8 were processed with the oligo package 58 and normalized using Robust Multi-array Average 59 . Multiple probes mapping into the same gene were summarized into a single expression value by taking the maximum. Affymetrix PrimeView arrays from Theunissen et al. 10 were processed with the Affy package 60 and normalized with RMA. Microarray differential expression analysis was performed using the limma package. RNA-seq and microarray data were combined as previously described 9 , and expression levels were converted to log 2 fold change relative to the mean of human embryo-derived PSC samples within each study. One-to-one orthologous genes between mouse-human were mapped as previously described 9 . PCA plots of all samples from all studies were generated using the princomp function from the R stats package.
An alternative PCA analysis was performed where the ComBat tool 61 was applied to correct for batch effects and naive samples were not normalized to primed samples. PCA was applied on batch effect-corrected, gene-wise meancentred expression values.
Global metabolomic data analysis. All global metabolomic data were meancentred within each sample. The prcomp function in R is used for principle component analysis of metabolomics data. Differentially abundant metabolites were defined as metabolites with a twofold change in abundance and a Benjamini-Hochberg adjusted false discovery rate < 0.2.
For the lipidomics data, features missing in more than half of all samples (4 or more out of 6) were removed from further analysis. Missing values were replaced with minimum detected values within each sample before mean centring.
ChIP-seq data analysis. ChIP-seq data of H3K27me3 H3K4me3, H3K9me3 and H3K27ac modifications from Chan et al. 6 , Gafni et al. 8 , Theunissen et al. 10 and Bernstein et al. 48 were downloaded from Array Express, GEO and the ENCODE project website. Reads were aligned to hg19 using Bowtie version 1.0.0. allowing 1 mismatch (-N 1). ngsplot was used to generate plots of reads around 5 kb of transcription start sites of a priori defined developmental genes. Reads of replicate samples for the same cell type were merged for ngsplot. Reads with mapping quality above 20 were used by ngsplot. Differentially marked genomic regions were identified with diffReps version 1. 55.4 (ref. 62 ) and annotated to the closest genes. Genes associated with at least one significant genomic region (FDR less than 0.05 and fold change > 1) were classified as differentially marked. When a gene is annotated with multiple significant genomic regions, the most significant one is assigned to that gene.
Lipid droplet visualization using Oil red O and BODIPY staining. Naive and
primed ESCs were fixed with 4% PFA at room temperature for 10 min, washed twice with PBS and stained with Oil red O dye (Sigma) for 10 min at room temperature. Alternatively, lipid droplets were stained using BODIPY 493/503 (Molecular Probes) for 15 min on a rocking platform at room temperature. Pictures were taken using a fluorescent microscope (Leica). Lipid droplet analysis at the in vivo postimplantation stage has proved to be difficult.
Protein extraction and western blot analysis. Cellular extracts were prepared using a lysis buffer containing 20 mM Tris HCl (pH 7.5), 150 mM NaCl, 15% glycerol, 1% Triton, 25 mM β-glycerolphosphate, 50 mM NaF, 10 mM Na pyrophosphate, orthovanadate, phenylmethylsulphonyl fluoride (all chemicals are from Sigma-Aldrich), Protease inhibitor cocktail (Roche) and 2% SDS. Twenty-five units of benzonase nuclease (EMD Chemicals) and 20 mM of dithiothreitol (Sigma) were added to the lysis buffer right before use. Fifteen micrograms of protein (determined by Bradford) was loaded, separated by 4-20% SDS-PAGE, and transferred to polyvinylidene difluoride membranes, blocked with 5% non-fat dry milk for 60 min at room temperature, and incubated overnight at 4 • C with primary antibody. After incubation for one hour with horseradish peroxidase-conjugated secondary antibodies, they were visualized by enhanced chemiluminescence (Millipore Corp). Antibodies used in this study are: H3K27me3 (1:1,000, Abcam, ab6002), H3K9me3 (1:1,000, Abcam, ab8898), H3K9/14Ac (1:1,000, Cell Signaling, 9677s), EED (1:1,000, gift from K. Bomsztyk 63 ), HIF1α (1:2,000, BD Biosciences, 610958), LDHA (1:1,000, Cell Signaling, 3582), JARID2 (1:1,000, Cell Signaling, 13594), pSTAT3 (1:1,000, Abcam, Ab76315) and γ-tubulin (1:10,000, Promega, G712A).
RNA extraction and qPCR analysis. RNA was extracted using Trizol and analysed by SYBRgreen qPCR with the 7300 real-time PCR system (Applied Biosystems) 64 and TaqMan qPCR (Applied Biosystems). Primers used are listed in Supplementary Table 2. qPCR of miRNAs was conducted using TaqMan miRNA assays (Applied Biosystems). Raw Ct values for miRNAs were normalized to RNU (ref. 63) . Linear expression values for all qPCR experiments were calculated using the 2 (− Ct) method. P values were calculated using Student's t-test.
ChIP-seq experiment. Naive hESCs Elf1 2iLIF grown on Matrigel were treated with 100 µM of STAT3 inhibitor (Selleckchem) for 6 h or 24 h and analysed for methylation marks by western blot and ChIP Seq. For ChIP-seq analysis, cells were crosslinked and chromatin processed as previously described 64 with minor modifications. Briefly, cells were collected with accutase and crosslinked in suspension with 1% formaldehyde solution for 10 min at room temperature. Reaction was quenched with glycine and crosslinked cells were rinsed with ice-cold PBS. Nuclei were isolated and chromatin sonicated using a Covaris E210 to approximately 200-500 bp size range. ChIP-seq was conducted as previously described 64 with minor modifications. Briefly, magnetic Dynabeads were incubated overnight rotating at 4 • C with antibody against H3K27me3 (Active Motif, cat. no. 39155). Sonicated chromatin from approximately 200,000 cells was added to the bead-bound-antibodies and incubated at 4 • C rotating overnight. Beads were washed and bound chromatin was eluted from beads and reverse crosslinked overnight. Purified DNA was prepared for next-generation sequencing through end repair, A-tailing, ligation of custom Y-adapters and PCR amplification to generate the final DNA library following gel size selection.
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Generation of BAR-Elf1 reporter cell line. Elf1 cells grown in naive media (2iF or 2iLIF) or primed media (AF) were infected with BAR reporter lentivirus 34, 65 and seeded onto Matrigel-coated plates in MEF-CM with 10 µM Y-27632, and 1 µM thiazovivin (ROCK inhibitors, Tocris). Transduced Elf1 cells were cultured for a week on Matrigel, and then passaged onto MEF plates for further selection and expansion. Single Elf1 naive reporter cells were collected using TrypLE Express and FACS sorted for the population with both Venus-and DsRed-positive signals. DsRed-positive colonies of Elf1 primed reporter cells were transferred onto MEF plates, and the same positive selection was repeated 1-2 more rounds. Negative colonies were removed as a negative selection.
Manipulation of Wnt pathway. Wnt secretion and signalling were inhibited in naive hESCs (Elf1, WIN1) by treatment with IWP2 (2 µM, Tocris) or XAV939 (5 µM, Sigma). The Wnt pathway was activated in primed Elf1 AF reporter cells using a GSK3 inhibitor, CHIR99021 (72 h, 10 µM, AxonMedChem). Both IWP2 and CHIR99021 were reconstituted in dimethylsulphoxide (DMSO).
Production of conditioned medium (LCM and Wnt3A-CM). L and L-Wnt3A cells (ATCC) were cultured in 15 cm plates in 10% FBS/DMEM media until ∼90% confluent. Medium was collected every 48 h for three batches. Biological activity of secreted Wnt3A in the individual batches of the conditional medium was confirmed in 293T-BAR reporter cells 34 , and then batches were pooled and filtered. Primed (Elf1 AF) reporter cells were grown on Matrigel with 50% LCM or 50% Wnt3A-CM for 3 days before taking bright-field and fluorescent pictures (Leica microscope).
RNA interference experiments. Naive Elf1 2iLIF cells were transfected on Matrigel
in MEF-CM supplemented with ROCK inhibitors (Tocris) using Lipofectamine RNAiMAX (Life Technologies). siRNA targeting NNMT (Hs-NNMT-8) was purchased from Qiagen as Flexitube siRNA premix, and siRNA targeting luciferase was used as control. siRNAs against NNMT and luciferase were used at 50 nM final concentration. Protein and RNA were extracted 72 h after transfection. siRNA targeting beta-catenin (Invitrogen, CTNNB1, Silencer Select ID s437) and Silencer Select Negative Control 1 (Invitrogen) were transfected in naive Elf1 2iLIF cells at a 10 nM final concentration following a reverse transfection protocol. Brightfield and fluorescence images were taken after 3 days. Efficacy was confirmed by qPCR analysis.
Overexpression of NNMT. Naive hESCs were transfected with NNMT overexpression construct or inactive NNMT mutant overexpression construct (Y20A; ref. 28) . Cells were plated the following day into Matrigel-coated Seahorse plates with primed hESC media (conditioned media + AF). The MitoStress protocol in the Seahorse flux analyser was performed 2 days later. Alternatively, primed hESCs Elf1 AF were transfected with NNMT overexpression construct 28 and proteins were extracted 3 days later for detection of H3K27me3 marks by western blot analysis.
Treatment of naive hESCs with the metabolite SAM. WIN1 cells were seeded in
Seahorse plates 2 days before change of media with media without L-methionine (Sigma-Aldrich 0422 supplemented with 0.584 gm l −1 L-glutamine (Invitrogen)) and addition of SAM (500 µM), and 5 h later the Seahorse MitoStress protocol was performed.
HIF1α overexpression in naive hESCs. Naive hESCs (Elf1) were infected with a non-degradable form of HIF1α overexpressing construct (Addgene plasmid 19005, Yan et al. 23 ) or a pBABE empty vector construct in the presence of 4 ng ml −1 Polybrene (Invitrogen). Twenty-four days later RNA and proteins were collected or medium was changed into naive hESC media with LIF but without GSK3 and MEK inhibitors (2i). Pictures were taken 3 days after infection and primed-like morphology of colonies quantified.
CRISPR-Cas9-based NNMT and HIF1 KO lines. Six gRNAs were designed
for each of the genes NNMT and HIF1α using the GECKO library and Zhang website (http://mit.edu) and annealed and ligated into the LentiCRISPRv2 (http:// Addgene.com), which was previously digested with BsmB1 and dephosphorylated. The validated constructs were transfected using GeneJuice to naive hESCs iCas9 Elf1 (ref. 66 ) treated with doxycycline (2 µg ml −1 ) for 1 or 2 days before and during transfection. On day 3 the cells were trypsinized and replated on MEFcoated plates. On day 6 single colonies were picked and amplified as described in Supplementary Fig. 8 . Genomic DNA was collected using DNAzol reagent (Invitrogen). NNMT KO 6.2.4 mutant was generated by transfecting in vitro transcribed gRNA to naive hESC Elf1 iCas9 cells 66 . T7-gRNA in vitro transcription (IVT) template (120 bp) was generated using T7 promoter-gRNA forward primer with a reverse primer against the scaffold. T7-gRNA PCR products were used as templates for IVT (MAXIscript T7 kit, Applied Biosystems). iCas9 Elf1 cells were treated with doxycycline (2 µg ml −1 ) for 1 or 2 days before and during transfection. For transfection, cells were dissociated with trypsin, replated onto MEF-coated plates, and transfected in suspension with gRNAs using Lipofectamine RNAiMAX (Life Technologies). gRNA was added at a 10 nM final concentration. A second transfection was performed after 24 h. Two days after the last gRNA transfection, iCas9 Elf1 cells were dissociated into single cells and replated onto MEF-coated plates. Single colonies were randomly selected and amplified. Genomic DNA was collected using DNAzol. Genomic regions flanking the CRISPR target sites were PCR amplified, purified and sent to Genewiz for sequencing. Alternatively, Samtools mpileup and BCF tools were used to identify variants on the basis of aligned RNAseq BAM files.
Teratoma formation. Naive hESCs H1 4iLIF were cultured on Matrigel-coated plates. Cells (2 × 10 6 ) were resuspended in Matrigel supplemented with a cocktail of prosurvival factors 29 and injected into the femoral muscle of female 43-49day-old SCID-Beige mice (Charles River). Palpable tumour masses developed in approximately 5 weeks. The tumour-bearing mice were euthanized, and tumour tissue was fixed in 10% formalin for 24 h and stored in 70% ethanol until paraffin embedding. Five-micrometre sections of the tumour were stained with haematoxylin and eosin ( Supplementary Fig. 1D ). The experiment was performed in compliance with ethical regulations, IACUC protocol no. 4152-01.
Embryonic body formation. H1 4iLIF naive-toggled cells were trypsinized and transferred into low-attachment plates in differentiation medium (DMEM, highglucose, 20% FBS, 0.1 mM NEAA, 2 mM L-glutamine, 1 mM sodium pyruvate, 1% Pen/Strep, 0.1 mM β-mercaptoethanol). The medium was changed every other day and whole genome RNA-seq was performed after 2 weeks ( Supplementary Table 1S ).
Accession numbers. RNA-seq and ChIP-seq data sets generated for this study are available from the NCBI GEO database under accession number GSE60955. Gene expression and ChIP-seq data from Grow et al. 46 Supplementary Table 4 . For HIF1α, LDHA and JARID2 western blots in Elf1, Elf1 AF and H7, there were 3 independent experiments (Fig. 1j,m) . For BODIPY 493/503 staining and Oil red O of lipid droplets in primed and naive human ( Fig. 3d and Supplementary Fig. 3A,B ) and mouse ( Fig. 3e ) ESCs, there were 4 independent experiments. For western blots of histone marks and EED in Elf1, Elf1 AF and H7 (Fig. 5b) there were 3 to 8 independent experiments. For western blots of histone marks in Elf1 and Elf1 treated with siRNA against NNMT or luciferase control ( Fig. 5d ) and Elf1 treated with STAT3 inhibitor or DMSO control ( Fig. 5f ) there were 3 independent experiments. For Wnt sensor analysis in naive and primed cells, there were 3 independent experiments (Fig. 6b,c and Supplementary  Fig. 6E,F) . For western blot analysis of HIF1α expression in cells pushed towards the primed stage (Fig. 7f ), there were 3 independent experiments. For western blot of HIF1α expression and H3K27me3 marks in Elf1 CRISPR-Cas9 KO mutants and control cells (Fig. 8e ), there were 4 independent experiments. For teratoma generated from H1 4iLIF ( Supplementary Fig. 1D ), there were 3 independent experiments. For western blot of H3K27me3 in Elf1 AF cells overexpressing NNMT ( Supplementary  Fig. 4I ), there were 3 independent experiments. For western blot of H3K27me3 marks in naive WIN1 and WIN1 TeSR, there were 3 independent experiments ( Supplementary Fig. 5H ). For western blot of HIF1α and H3K27me3 in WIN1 cells after transfection with siRNA against NNMT or luciferase ( Supplementary Fig. 5L ) there were 3 independent experiments. For western blot of phosphorylated STAT3 in H1 and H1 2iF ( Supplementary Fig. 5M ), there were 2 independent experiments. For morphology of Elf1 transfected with EV or HIF1α OE, there were 3 independent experiments ( Supplementary Fig. 7B ).
There is no estimate of variation in each group of data and the variance is similar between the groups. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. RNA samples with 260 nm/280 nm <1.80 were discarded. Supplementary Figure 3 Lipid metabolism in naive and primed human and mouse ESCs. A: Lipid droplets are known to be increased in human pluripotent and embryonic stem cells 67, 68 . BODIPY 493/503 staining shows an increase of lipid droplet accumulation in primed hESCs (H7, H1, Elf1 AF) compared to naïve hESCs (Elf1, H1 2iF, H1 4iLIF). Images were taken at 5X magnification. Scale bar represents 100µm. B: Oil Red O staining shows an increase of lipid droplet accumulation in primed hESCs (H7) compared to naïve hESCs (Elf1). Scale bar represents 20µm. C: H3K27me3 reads mapped 5kb around transcription start site (TSS) of CPT1A were plotted for Chan et al ChIP-seq data sets. Primed cells have more H3K27me3 repressive marks around TSS of CPT1A. D: Expression of key genes involved in fatty acid synthesis from RNA-seq analysis in naïve (Elf1, n=2) and primed (H1, n=1) hESCs. Negative binomial test p-values are shown. E: A trace of OCR changes under Seahorse palmitate assay with addition of 2 doses of palmitate or BSA vehicle followed by 2 doses of ETO in hESCs H1 pushed toward a more naïve state using 4iLIF (H1 4iLIF) and primed hESCs H1. n=6 for H1BSA, n=5 for H1PALM, H1 4iLIF BSA and H1 4iLIF PALM. F: More abundant lipids in primed human cells (Elf1AF) are more unsaturated than more abundant lipids in naïve human cells (Elf1), n=6. G: More abundant lipids in primed mouse cells (EpiSC) have more carbon atoms than more abundant lipids in naïve mouse cells (R1), n=6. Boxes represent median, 25 th and 75 th quantiles. Whiskers extend 1.5 IQR above 75 th quantile and below 25 th quantile. Dots represent values beyond whiskers. H-I: Relative fold change of expression of genes involved in transport of fatty acids into mitochondria and genes involved in 4 steps of fatty acid beta-oxidation from RNASeq analysis in human ESCs (H1 vs. Elf1, H) and mouse ESCs (Epiblasts vs.ICM, I). Three isoforms have been described: CPT1A, CPT1B and CPT1C; however, CPT1C is not involved in fatty acid beta-oxidation 48 . For raw data, see Supplementary Table 4 . n= number of biological replicates. 
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Supplementary Figure 4 Tryptophan and SAM metabolic pathways in naive and primed hESCs. A: RNA expression of IDO1 in human 8-cell embryo and primed hESCs at passage 0 (hESCp0) and 10 (hESCp10) analyzed by single cell RNA Seq data 23 . B: RNA expression of IDO1, IDO2, TDO2 and AADAT in naïve hESCs Elf1, primed hESCs H1 and H1 differentiated during 4 days 12,49 detected by microarray (n=2). C: IDO expression in H1 cells and H1 differentiated toward various lineages 47 , n=2, error bar represents 2 SEM above and below the mean. D: NNMT expression in various tissues analyzed by RNASeq 50 . E: NNMT expression in various organs of rats over time (from 2 to 104 weeks) analyzed by RNASeq 50 . F: NNMT expression in H1 cells and H1 differentiated toward various lineages 47 . G-H: Primed hESCs (H1 n=4, ELF AF n=6, WIN1 TESR n=6) have higher amounts of nicotinamide (G) and SAM (H), than naïve hESCs (WIN1 n=4, Elf1 n=4, H1 2iF n=4, H1 4iLIF n=4). S.e.m.; p=0.0019 for nicotinamide, p=0.0026 for SAM; 2-tailed t-test. I: Overexpression of NNMT decreases H3K27me3 marks in primed Elf AF cells 3 days after transient transfection. Antibody against NNMT detected a single band around 50kDA. Unprocessed original scans of blots are shown in Supplementary Fig.9 . For raw data, see Supplementary Table 4 . n= number of biological replicates. Supplementary Fig.9 . For raw data, see Supplementary Table 4 . n= number of biological replicates. Figure 7 Responses to HIF1 overexpression and knockout experiments. A:Expression of IDO1 in naïve hESCs (Elf1) after infection with an empty vector (EV) or HIF1 overexpressing (HIF1 OE) virus, analyzed by qPCR (n=2 independent replicates). B-C: HIF1α OE pushes in Elf1 cells toward primed-like cells. When cultured in a "permissive media" (with LIF but without GSK3 and MEK inhibitors) naïve hESCs Elf1α overexpressing HIF1α for 3 days show higher percentage of primed hESC-like colonies than cells infected with an empty vector control (EV). Morphology is shown in B and quantification of the percentage of primed hESC-like colonies in C. Scale bar represents 200µm. n=261 (EV) and n=327 (HIF1 OE) colonies were counted from 3 independent experiments, s.e.m, * p=0.0183, 2-tailed t-test. D: Analysis of mutation in the CRISPR-Cas9 KO of HIF1α (Elf1 gHIF1 6.2.1) by RNA seq: the variant site carries the AG -> AGG insertion, as noted by the purple insertion symbol. E: A trace of OCR following mitostress protocol in CRISPR HIF1α KO cells (gHIF1 6.2.1) in cultured in naïve conditions or pushed to primed for 3 days (AF D3). N=6 ; s.e.m. For raw data, see Supplementary Table 4 . n= number of biological replicates. Supplementary Figure 9 continued 
